Equazen Acumen 60 caps ACU

Product Overview

Each serving of our Equazen® Acumen™ supplement contains 320 mg of Bacopa monnieri extract CDRI 08^®‡ that has been tested in clinical studies.

Bacopa monnieri is a neuroprotective, adaptogenic herb used for centuries in Ayurvedic medicine to improve mental sharpness and memory.^1,2

It supports brain resilience against oxidative stress and enhances retention of newly learned information,³ while also supporting stress reduction and positive mood, seen as early as an hour after consuming the product. ^†4

Benefits

• Supports cognitive function^†   
• Improves mental sharpness and working memory^†
• Helps maintain focus and balanced mood^†

Who Can Benefit

• Students
• Working professionals
• Elderly individuals

Key Features

Bacopa monnieri Extract (CDRI 08^®‡): A specific Bacopa monnieri extract, CDRI 08^®‡ has been the focus of extensive scientific research.

Supports Neuronal Cell Health and Communication: Equazen^® Acumen™ aids in balancing neurotransmitter activity, promoting improved mood, memory, and cognitive function.^†

Safe for Adults and Children: Adults and children as young as six can tolerate Equazen® Acumen™.

Detailed Overview

Each serving of Equazen^® Acumen™ delivers 320 mg of Bacopa monnieri extract CDRI 08^®‡, which has undergone rigorous clinical testing.

Bacopa monnieri, a neuroprotective adaptogen, has been used for centuries in Ayurvedic medicine to enhance cognitive acuity and memory retention.

This herb actively protects the brain against oxidative stress and optimizes neurotransmitter communication, supporting overall neural efficiency.^†

 Storage 

•  Store in a cool, dry place (59°-85°F) away from direct light.

Reference

1. Vollala VR, Upadhya S, Nayak S. Enhanced dendritic arborization of hippocampal CA3 neurons by Bacopa monniera extract treatment in adult rats. Rom J Morphol Embryol. 2011;52(3):879-886.

2. Stough C, Lloyd J, Clarke J, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects [published correction appears in Psychopharmacology (Berl). 2015 Jul;232(13):2427. Dosage error in article text]. Psychopharmacology (Berl). 2001;156(4):481-484. doi:10.1007/s002130100815

3. Roodenrys S, Booth D, Bulzomi S, Phipps A, Micallef C, Smoker J. Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology. 2002;27(2):279-281.

doi:10.1016/S0893-133X(01)00419-5

4. Benson S, Downey LA, Stough C, Wetherell M, Zangara A, Scholey A. An acute, double-blind, placebo-controlled cross-over study of 320 mg and 640 mg doses of Bacopa monnieri (CDRI 08) on multitasking stress reactivity and mood. Phytother Res. 2014;28(4):551-559. doi:10.1002/ptr.5029

5. Raghav S, Singh H, Dalal PK, Srivastava JS, Asthana OP. Randomized controlled trial of standardized Bacopa monniera extract in age-associated memory impairment. Indian J Psychiatry. 2006;48(4):238-242. doi:10.4103/0019-5545.31555

6. Stough C, Downey LA, Lloyd J, et al. Examining the nootropic effects of a special extract of Bacopa monniera on human cognitive functioning: 90 day double-blind placebo-controlled randomized trial. Phytother Res. 2008;22(12):1629-1634. doi:10.1002/ptr.2537

7. Kean JD, Downey LA, Stough C. A systematic review of the Ayurvedic medicinal herb Bacopa monnieri in child and adolescent populations. Complement Ther Med. 2016;29:56-62. doi:10.1016/j.ctim.2016.09.002